| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Patrick C Wilson | |
| Christopher T Stamper | |||
| P2860 | cites work | Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation | Q36403602 |
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. | Q36627503 | ||
| Antibody diversification by somatic mutation: from Burnet onwards | Q37052624 | ||
| Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1. | Q38219407 | ||
| Antibody B cell responses in HIV-1 infection | Q38252874 | ||
| Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes | Q38388195 | ||
| Germinal center selection and the antibody response to influenza | Q38615063 | ||
| Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design. | Q38632666 | ||
| HIV-Host Interactions: Implications for Vaccine Design | Q26765966 | ||
| Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses | Q26998642 | ||
| Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody | Q27644415 | ||
| Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design | Q27644634 | ||
| Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization | Q27677117 | ||
| Predominant autoantibody production by early human B cell precursors | Q29619656 | ||
| Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. | Q30352862 | ||
| Advances in the development of influenza virus vaccines. | Q30372164 | ||
| Immune history profoundly affects broadly protective B cell responses to influenza. | Q30382131 | ||
| Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza | Q30389700 | ||
| Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 | ||
| Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter | Q30498133 | ||
| Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline | Q34075820 | ||
| Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes | Q34270980 | ||
| Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China | Q34350881 | ||
| Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation | Q35127575 | ||
| HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen | Q35969973 | ||
| P577 | publication date | 2017-06-19 | |
| P1433 | published in | Cold Spring Harbor Perspectives in Biology | Q3927509 |
| P1476 | title | What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Is Affinity Maturation a Self-Defeating Process for Eliciting Broad Protection? |
Search more.